切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2026, Vol. 15 ›› Issue (02) : 69 -75. doi: 10.3877/cma.j.issn.2095-3216.2026.02.002

论著

耗竭肾组织自然杀伤细胞改善叶酸诱导的小鼠急性肾损伤
陈柏源1, 林其圣2, 林青霞1, 杨渊婷2, 倪兆慧2, 周磊1,()   
  1. 1200127 上海交通大学医学院附属仁济医院、上海市免疫治疗创新研究院
    2200127 上海交通大学医学院附属仁济医院肾脏科
  • 收稿日期:2025-09-11 出版日期:2026-04-28
  • 通信作者: 周磊
  • 基金资助:
    国家自然科学基金面上项目(32270943)

Depletion of renal natural killer cells ameliorates folic acid-induced acute kidney injury in mice

Baiyuan Chen1, Qisheng Lin2, Qingxia Lin1, Yuanting Yang2, Zhaohui Ni2, Lei Zhou1,()   

  1. 1Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Innovation Institute of Immunotherapy; Shanghai 200127, China
    2Department of Nephrology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Shanghai 200127, China
  • Received:2025-09-11 Published:2026-04-28
  • Corresponding author: Lei Zhou
引用本文:

陈柏源, 林其圣, 林青霞, 杨渊婷, 倪兆慧, 周磊. 耗竭肾组织自然杀伤细胞改善叶酸诱导的小鼠急性肾损伤[J/OL]. 中华肾病研究电子杂志, 2026, 15(02): 69-75.

Baiyuan Chen, Qisheng Lin, Qingxia Lin, Yuanting Yang, Zhaohui Ni, Lei Zhou. Depletion of renal natural killer cells ameliorates folic acid-induced acute kidney injury in mice[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2026, 15(02): 69-75.

目的

探究耗竭小鼠肾组织自然杀伤(natural killer,NK)细胞对叶酸诱导小鼠急性肾损伤(acute kidney injury,AKI)的作用。

方法

选取C57BL/6J雄性8~10周龄小鼠,随机分为模型组(腹腔注射叶酸250 mg/kg)、模型+抗小鼠IgG2a抗体组(建模前连续2 d腹腔注射IgG2a抗体200 μg)、模型+抗小鼠NK1.1抗体组(建模前连续2 d腹腔注射NK1.1抗体200 μg)和对照组(腹腔注射等量0.3 M碳酸氢钠),每组均5只。各组小鼠于造模后2 d取材,检测血清肌酐、尿素氮、肾脏/体重质量百分比及肾组织病理学改变;流式细胞术分析肾组织中CD4T细胞、CD8T细胞、调节性T细胞、NK细胞的比例,并检测其分泌白细胞介素-17A、干扰素-γ、肿瘤坏死因子-α的能力。模型+抗小鼠IgG2a抗体组、模型+抗小鼠NK1.1抗体组造模后2 d以流式细胞术检测肾组织NK细胞耗竭水平,分析肾功能变化,并观察肾脏病理改变。

结果

与对照组相比,模型组小鼠血清肌酐、血尿素氮水平较高,肾组织损伤更严重(P均<0.05),肾组织中NK细胞比例较高(P<0.05),其细胞因子干扰素-γ减少、肿瘤坏死因子-α增多(P均<0.05),而肾组织中的CD4T细胞、CD8T细胞和调节性T细胞比例及其细胞因子则无明显改变。与模型+抗小鼠IgG2a抗体组相比,模型+抗小鼠NK1.1抗体组小鼠的肾组织NK细胞显著耗竭,血清肌酐和血尿素氮水平较低,肾组织损伤较轻(P均<0.05)。

结论

使用抗小鼠NK1.1抗体能够显著耗竭小鼠的肾组织NK细胞,减轻叶酸诱导的小鼠AKI,其保护机制与减少小鼠肾组织中的NK细胞浸润、降低促炎细胞因子分泌有关。

Objective

To investigate the effect of depleting renal natural killer (NK) cells on folic acid-induced acute kidney injury (AKI) in mice.

Methods

Male C57BL/6J mice aged 8-10 weeks old were selected and randomly divided into the following groups (n=5 per group): a model group (intraperitoneal injection of folic acid at 250 mg/kg), a model+ anti-mouse IgG2a antibody group (intraperitoneal injection of 200 μg IgG2a antibody for 2 consecutive days prior to modeling), a model+ anti-mouse NK1.1 antibody group (intraperitoneal injection of 200 μg anti-NK1.1 antibody for 2 consecutive days prior to modeling), and a control group (intraperitoneal injection of an equivalent volume of 0.3 M NaHCO3). Mice of the control and model groups were sacrificed 2 days after modeling to evaluate serum creatinine, blood urea nitrogen, kidney-to-body weight ratio, and renal histopathological changes. Flow cytometry was performed to analyze the proportions of CD4+ T cells, CD8+ T cells, regulatory T cells, and NK cells in kidney tissues, as well as their capacity to secrete cytokines as interleukin-17A, interferon-γ, and tumor necrosis factor-α. For the model+ anti-mouse IgG2a antibody group and the model+ anti-mouse NK1.1 antibody group, the renal NK cells depletion efficiency was assessed by flow cytometry 2 days after modeling, along with the analysis of renal function and observation of renal pathological changes.

Results

Compared with the control group, the model group showed significantly higher serum creatinine and blood urea nitrogen levels, as well as more severe renal tissue injury (all P<0.05), while the proportion of NK cells in the kidneys was also significantly increased (P<0.05), accompanied by decreased interferon-γ and increased tumor necrosis factor-α secretion (all P<0.05). In contrast, the proportions of CD4+ T cells, CD8+ T cells, and regulatory T cells, along with their associated cytokines, showed no significant changes in the renal tissues. Compared with the model+ anti-mouse IgG2a antibody group, the model + anti-mouse NK1.1 antibody group exhibited significant renal NK cells depletion, accompanied by lower serum creatinine and blood urea nitrogen levels and attenuated renal tissue injury (all P<0.05).

Conclusion

The use of anti-mouse NK1.1 antibody significantly depleted NK cells in renal tissues and attenuated folic acid-induced AKI in mice, suggesting that its protective mechanism is associated with reduced NK cells infiltration and decreased pro-inflammatory cytokines secretion in the kidneys.

图1 模型组与对照组小鼠血清生化指标、肾/体重质量百分比及肾脏病理结果注:A:模型组与对照组小鼠的血清肌酐、血尿素氮水平及肾/体重质量百分比的比较;B:模型组与对照组小鼠肾组织苏木精-伊红染色(比例尺250 μm); C:模型组与对照组小鼠肾组织苏木精-伊红染色病理损伤评分比较;与对照组相比,aP<0.05
图2 模型组与对照组小鼠肾组织中免疫细胞比例及相应细胞因子检测注:A:模型组与对照组小鼠肾组织NK细胞占总淋巴细胞的细胞比例;B:模型组与对照组小鼠肾组织NK细胞分泌TNFα、IFNγ的功能比较;与对照组相比,aP<0.05; C:模型组与对照组小鼠肾组织CD4T、CD8T细胞、Treg细胞占总淋巴细胞的细胞比例;D:模型组与对照组小鼠肾组织CD4T细胞分泌IL-17A、IFNγ的功能比较、CD8T细胞分泌TNFα的功能比较;NK:natural killer,自然杀伤;TNFα:tumor necrosis factor-α,肿瘤坏死因子-α;IFNγ:interferon-γ,干扰素-γ;IL-17A:白细胞介素-17A
图3 耗竭自然杀伤细胞减轻肾脏急性损伤实验注:A:流式细胞术检测NK细胞耗竭水平;B:模型+抗小鼠IgG2a抗体组、模型+抗小鼠NK1.1抗体组小鼠肾组织NK细胞的细胞比例;C:模型+抗小鼠IgG2a抗体组、模型+抗小鼠NK1.1抗体组的血清肌酐、血尿素氮水平比较;D:模型+抗小鼠IgG2a抗体组、模型+抗小鼠NK1.1抗体组小鼠肾组织苏木精-伊红染色结果及病理损伤评分比较;与模型+抗小鼠IgG2a抗体组,aP<0.05
[1]
Lee K, Jang HR, Rabb H. Lymphocytes and innate immune cells in acute kidney injury and repair [J]. Nat Rev Nephrol, 2024, 20(12): 789-805.
[2]
Kellum JA, Romagnani P, Ashuntantang G, et al. Acute kidney injury [J]. Nat Rev Dis Primers, 2021, 7(1): 52.
[3]
Jang HR, Rabb H. Immune cells in experimental acute kidney injury [J]. Nat Rev Nephrol, 2015, 11(2): 88-101.
[4]
Vivier E, Rebuffet L, Narni-Mancinelli E, et al. Natural killer cell therapies [J]. Nature, 2024, 626(8000): 727-736.
[5]
Victorino F, Sojka DK, Brodsky KS, et al. Tissue-resident NK cells mediate ischemic kidney injury and are not depleted by anti-asialo-GM1 antibody [J]. J Immunol, 2015, 195(10): 4973-4985.
[6]
李孟坤,张雅宾,敖强国,等. 三种急性肾脏病小鼠模型的建立及肾脏功能和病理比较[J/OL]. 中华肾病研究电子杂志2025, 14(1): 18-25.
[7]
Lin Q, Li S, Jiang N, et al. Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy [J]. Autophagy, 2021, 17(10): 2975-2990.
[8]
Devant P, Kagan JC. Molecular mechanisms of gasdermin D pore-forming activity [J]. Nat Immunol, 2023, 24(7): 1064-1075.
[9]
Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis [J]. Nat Rev Nephrol, 2019, 15(3): 144-158.
[10]
Tadagavadi RK, Reeves WB. Renal dendritic cells ameliorate nephrotoxic acute kidney injury [J]. J Am Soc Nephrol, 2010, 21(1): 53-63.
[11]
Danelli L, Madjene LC, Madera-Salcedo I, et al. Early phase mast cell activation determines the chronic outcome of renal ischemia-reperfusion injury [J]. J Immunol, 2017, 198(6): 2374-2382.
[12]
Uchida T, Seki S, Oda T. Infections, reactions of natural killer t cells and natural killer cells, and kidney injury [J]. Int J Mol Sci, 2022, 23(1): 479.
[13]
Pefanis A, Ierino FL, Murphy JM, et al. Regulated necrosis in kidney ischemia-reperfusion injury [J]. Kidney Int, 2019, 96(2): 291-301.
[14]
Stary V, Pandey RV, Strobl J, et al. A discrete subset of epigenetically primed human NK cells mediates antigen-specific immune responses [J]. Sci Immunol, 2020, 5(52): eaba6232.
[1] 中国临床肿瘤学会乳腺癌专家委员会, 中国医师协会肿瘤多学科诊疗专业委员会, 广东省药学会. 乳腺癌内分泌治疗超说明书用药专家共识[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(02): 69-81.
[2] 杨荣华. 基于细菌生物膜对难愈性创面的诊治[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(02): 160-160.
[3] 张永宏, 徐玉沙, 邓如非, 姜臻宇, 张友来, 邹立津, 辛国华. 非药物干预疗法减轻烧伤患者疼痛的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(02): 127-131.
[4] 李广鑫, 权慧娟, 高志娟, 李良, 王肖君, 曹玉庆. 腹腔镜急诊切除与支架置入限期切除治疗梗阻性结直肠癌的临床效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(02): 142-145.
[5] 李坚, 张伟, 曾少杰, 母德安. 经皮穿刺消融治疗与腹腔镜肝脏切除术治疗早期肝内胆管癌的临床效果对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(02): 187-190.
[6] 李俊杰, 董培, 姚成, 刘泽, 李勇. 前列腺癌免疫治疗的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(02): 209-215.
[7] 周明宽, 罗程, 庄锦涛, 涂响安. 广东省医学会泌尿外科疑难病例多学科会诊(第28期)——阴茎癌并双侧腹股沟、髂外动脉旁淋巴结转移[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(02): 231-236.
[8] 胡倩雯, 徐铭亿, 孙珊, 苏刚, 张珊珊, 张文霞, 史明霞, 张磊升, 李金文. 急性B淋巴细胞白血病患者骨髓来源NK细胞的生物学表型特征[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(02): 65-73.
[9] 方睿, 于胜强. 干细胞外泌体介导的肾脏保护:阻止纤维化进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(02): 94-101.
[10] 谢伟, 张小峰, 沈锋. 肿瘤免疫治疗相关不良事件的流行病学特征、发生机制和防治策略[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 146-151.
[11] 崔梦玲, 孙文梅, 赵睿敏, 王家平. 合并微血管侵犯肝癌术后TACE联合治疗的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 160-166.
[12] 李勃, 叶威良, 张静雯, 上文文. 叶酸-聚乙二醇-阿霉素连接物对肝癌裸鼠皮下移植瘤生长及心脏毒性影响的研究[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(02): 101-107.
[13] 常莉娜, 刘囡囡. DWI联合DCE-MRI定量参数对局部进展期直肠癌新辅助治疗后病理完全缓解的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(02): 125-129.
[14] 王明辉, 李文波, 李群, 马增翼, 吴文明, 王静, 孙奎林, 张保娟, 刘晓峰. 早期内镜止血治疗在胃底静脉曲张组织胶注射后排胶溃疡出血中的应用[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(02): 151-155.
[15] 宋文迪, 孙蔚, 宋海庆. 脑卒中后平衡障碍的发生机制及治疗的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(02): 111-118.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?